| 11th Dec 2013 3:31 pm |
RNS |
Board Committee change |
| 10th Dec 2013 5:16 pm |
RNS |
Transaction in Own Shares |
| 9th Dec 2013 5:28 pm |
RNS |
Transaction in Own Shares |
| 9th Dec 2013 3:54 pm |
RNS |
Director/PDMR Shareholding |
| 5th Dec 2013 5:53 pm |
RNS |
Transaction in Own Shares |
| 4th Dec 2013 5:12 pm |
RNS |
Transaction in Own Shares |
| 3rd Dec 2013 5:31 pm |
RNS |
Transaction in Own Shares |
| 2nd Dec 2013 5:03 pm |
RNS |
Transaction in Own Shares |
| 29th Nov 2013 5:19 pm |
RNS |
Transaction in Own Shares |
| 29th Nov 2013 12:40 pm |
RNS |
Director/PDMR Shareholding |
| 28th Nov 2013 5:48 pm |
RNS |
Transaction in Own Shares |
| 27th Nov 2013 5:24 pm |
RNS |
Transaction in Own Shares |
| 25th Nov 2013 5:14 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Nov 2013 1:43 pm |
RNS |
Tivicay® (dolutegravir) - positive CHMP opinion |
| 20th Nov 2013 7:00 am |
RNS |
GSK completes partial sale of Aspen |
| 19th Nov 2013 3:21 pm |
RNS |
GSK intends to divest part holding in Aspen |
| 18th Nov 2013 5:40 pm |
RNS |
Director/PDMR Shareholding |
| 18th Nov 2013 1:16 pm |
RNS |
Relvar Ellipta receives EC marketing authorisation |
| 15th Nov 2013 5:21 pm |
RNS |
Blocklisting Interim Review |
| 15th Nov 2013 5:16 pm |
RNS |
Director/PDMR Shareholding |
| 15th Nov 2013 5:10 pm |
RNS |
Transaction in Own Shares |
| 14th Nov 2013 5:17 pm |
RNS |
Transaction in Own Shares |
| 13th Nov 2013 5:28 pm |
RNS |
Transaction in Own Shares |
| 12th Nov 2013 3:52 pm |
RNS |
Director/PDMR Shareholding |
| 12th Nov 2013 3:51 pm |
RNS |
Director/PDMR Shareholding |
| 12th Nov 2013 7:01 am |
RNS |
darapladib Phase III Study Results |
| 11th Nov 2013 5:06 pm |
RNS |
Director/PDMR Shareholding |
| 1st Nov 2013 5:29 pm |
RNS |
Transaction in Own Shares |
| 1st Nov 2013 12:46 pm |
RNS |
Total Voting Rights |
| 31st Oct 2013 5:17 pm |
RNS |
Transaction in Own Shares |
| 30th Oct 2013 5:30 pm |
RNS |
Transaction in Own Shares |
| 28th Oct 2013 5:38 pm |
RNS |
Transaction in Own Shares |
| 28th Oct 2013 3:42 pm |
RNS |
Director/PDMR Shareholding |
| 25th Oct 2013 5:07 pm |
RNS |
Transaction in Own Shares |
| 25th Oct 2013 3:03 pm |
RNS |
Director/PDMR Shareholding |
| 25th Oct 2013 1:00 pm |
RNS |
Dolutegravir Trii - EU Regulatory Submission |
| 23rd Oct 2013 12:00 pm |
RNS |
3rd Quarter Results |
| 22nd Oct 2013 5:17 pm |
RNS |
US FDA submission for Tivicay combination |
| 22nd Oct 2013 4:47 pm |
RNS |
Transaction in Own Shares |
| 21st Oct 2013 4:54 pm |
RNS |
Transaction in Own Shares |
